Detalles de la búsqueda
1.
The Ratio of the Number of Biopsy Specimens to Prostate Volume (Biopsy Density) Greater Than 1.5 Improves the Prostate Cancer Detection Rate in Men Undergoing Transperineal Biopsy of the Prostate.
J Urol
; 202(2): 264-271, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30835628
2.
Stage T3b prostate cancer diagnosed by seminal vesicle biopsy and treated with neoadjuvant hormone therapy, permanent brachytherapy and external beam radiotherapy.
BJU Int
; 123(2): 277-283, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29956864
3.
Outcomes and toxicities in patients with intermediate-risk prostate cancer treated with brachytherapy alone or brachytherapy and supplemental external beam radiation therapy.
BJU Int
; 121(5): 774-780, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29319919
4.
Low-dose-rate brachytherapy for prostate cancer: outcomes at >10 years of follow-up.
BJU Int
; 121(5): 781-790, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29319928
5.
Factors influencing long-term urinary symptoms after prostate brachytherapy.
BJU Int
; 122(5): 831-836, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29726091
6.
Editorial Comment to Local dose (biological effective dose <180 Gy2) is an important predictor of biochemical recurrence in patients undergoing low-dose-rate brachytherapy.
Int J Urol
; 29(12): 1568, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36305700
7.
15-year cause specific and all-cause survival following brachytherapy for prostate cancer: negative impact of long-term hormonal therapy.
J Urol
; 192(3): 754-9, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24698961
9.
Trimodality Therapy With Iodine-125 Brachytherapy, External Beam Radiation Therapy, and Short- or Long-Term Androgen Deprivation Therapy for High-Risk Localized Prostate Cancer: Results of a Multicenter, Randomized Phase 3 Trial (TRIP/TRIGU0907).
Int J Radiat Oncol Biol Phys
; 118(2): 390-401, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37802225
10.
A unified strategy to focal brachytherapy incorporating transperineal biopsy, image fusion, and real-time implantation with and without rectal spacer simulated in prostate phantoms.
J Contemp Brachytherapy
; 16(2): 139-149, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38808209
11.
Risk of urinary incontinence following post-brachytherapy transurethral resection of the prostate and correlation with clinical and treatment parameters.
J Urol
; 190(5): 1805-10, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23669568
12.
A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of urinary symptoms after radiotherapy for prostate cancer.
J Urol
; 190(1): 102-8, 2013 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-23376709
13.
Low dose rate prostate brachytherapy in younger men.
BJU Int
; 121(1): 2, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29314535
14.
Temporal patterns of selected late toxicities in patients treated with brachytherapy or brachytherapy plus external beam radiation for prostate adenocarcinoma.
BJU Int
; 111(3 Pt B): E43-7, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23046084
15.
The relative importance of hormonal therapy and biological effective dose in optimizing prostate brachytherapy treatment outcomes.
BJU Int
; 112(2): E44-50, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23773225
16.
Haematuria after prostate brachytherapy.
BJU Int
; 111(8): E319-24, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23360671
17.
Factors influencing urinary symptoms 10 years after permanent prostate seed implantation.
J Urol
; 187(1): 117-23, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22114818
18.
Tri-Modality therapy with I-125 brachytherapy, external beam radiation therapy, and short- or long-term hormone therapy for high-risk localized prostate cancer (TRIP): study protocol for a phase III, multicenter, randomized, controlled trial.
BMC Cancer
; 12: 110, 2012 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-22439742
19.
Long-term potency preservation following brachytherapy for prostate cancer.
BJU Int
; 110(2): 221-5, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22734475
20.
Gleason 7 prostate cancer treated with low-dose-rate brachytherapy: lack of impact of primary Gleason pattern on biochemical failure.
BJU Int
; 110(9): 1257-61, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22571680